ARCHIVES

Phase III Trial Would Give Clearer Picture of C225 Role

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

March 26, 2010

John Mendelson Says M.D. Anderson Plans to Accelerate Role In Translational Research

May 7, 1999

New Jersey Commission Calls For Major Hike In Cancer Spending

September 25, 1987

New CCOP RFA Available; Briefing At ASCO Jammed

June 2, 1989

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Protocols Approved By NCI During January 2004

February 27, 2004